QUALITY OF LIFE, COUNSELLING AND HORMONE REPLACEMENT THERAPY
AbstractBACKGROUND Biomedical discourse dominates research literature and media accounts of menopause.Symptoms of menopause and psychosocial, cultural and interpersonal interactions inevitably influence the quality of life.In this article, different views on menopause are presented: from the standpoints ofwomen, men, and medical experts. Treatment decisions can be made between hormonalreplacement therapy and other, less researched remedies. Shared decision makingsignificantly improves adherence to treatment and facilitates better treatment outcomes.This can be made possible if the patient is adequately informed about the benefits and risksof the therapy. A trusting relationship between the doctor and patient and excellentcommunication between them is a key to better outcomes. The article brings an overviewof some of the research on quality of life in menopause, and counselling concerninghormonal replacement therapy. CONCLUSIONS Quality of life in menopause is a result of many factors and therefore it is very individual.Hormone replacement therapy is one of the possibilities of improvement. Therefore, it isessential that a woman is adequately informed about all the advantages and risks of thehormonal replacement therapy. Only an informed patient can be a partner in shareddecision making about the improvement of quality of life
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.